Market Tracker

04/17 6:05pm ET

NewLink Genetics Corp (NASDAQ:NLNK)

20.85
Data as of Apr 17
 -0.24 / -1.14%
Today’s Change
11.23
Today|||52-Week Range
53.48
-5.27%
Year-to-Date
No recent news for NewLink Genetics Corp.

Today’s Trading

Previous close21.09
Today’s open21.09
Day’s range19.88 - 21.36
Volume410,997
Average volume (3 months)638,705
Market cap$627.2M
Dividend yield--
Data as of 4:00pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)-9.82%
Earnings growth (this year)-36.72%
Earnings growth (next 5 years)--
Revenue growth (last year)-35.21%
P/E ratioNM
Price/Sales508.97
Price/Book10.26

Competitors

 Today’s
change
Today’s
% change
OREXOrexigen Therapeutic...-0.08-1.49%
PTCTPTC Therapeutics Inc-0.99-5.01%
INSMInsmed Inc+0.88+7.02%
ENTAEnanta Pharmaceutica...+0.26+0.78%
Data as of 3:59pm ET, 04/17/2014

Financials

Next reporting dateMay 8, 2014
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$1.1M
Annual profit (last year)-$31.2M
Net profit margin-2,852.70%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts